Clarity strengthens protection of SAR-bisPSMA product with China patent

September 13, 2022 Australian Biotech

This is a preview of subscriber content

Subscribe now to continue reading.

Clinical stage radiopharmaceutical company Clarity Pharmaceuticals (ASX:CU6) has announced that a patent application covering its optimised Prostate Specific Membrane Antigen targeting agent, SAR-bisPSMA, has been granted in China. …

Subscribe now to continue reading.

Latest Video

How education exposes the moral and ethical limits of our health decision-making
August 11, 2026 - Latest News
Australia 'is not an island' on pricing and we cannot be so arrogant to expect free product
August 13, 2026 - Latest News
Former minister joins DBG Health board as company broadens healthcare ambition
August 12, 2026 - Latest News
US childhood vaccine move away from combinations contrasts with Australia’s national schedule
August 12, 2026 - Latest News
Patients welcome the timely PBS listing of rare cancer therapy
August 12, 2026 - Latest News

Clarity strengthens protection of SAR-bisPSMA product with China patent

This is a preview of subscriber content

Latest Video

Most Read

How education exposes the moral and ethical limits of our health decision-making

Australia 'is not an island' on pricing and we cannot be so arrogant to expect free product

Former minister joins DBG Health board as company broadens healthcare ambition

US childhood vaccine move away from combinations contrasts with Australia’s national schedule

Patients welcome the timely PBS listing of rare cancer therapy

New Stories

An institution dominated by very clever people, but where is the wisdom?

A plain language version of these dreadful and useless documents

CUREator+ backs six Australian startups with $13.5 million to advance new health technologies

Medicines Australia appoints former AbbVie executive to key leadership role

VVMF and Optosleep partner to advance Australian gene therapy for sleep apnoea

Survey exposes deep gaps in neurological care across Australia

Australia 'is not an island' on pricing and we cannot be so arrogant to expect free product

Sign In

Clarity strengthens protection of SAR-bisPSMA product with China patent

This is a preview of subscriber content

Latest Video

Most Read

How education exposes the moral and ethical limits of our health decision-making

Australia 'is not an island' on pricing and we cannot be so arrogant to expect free product

Former minister joins DBG Health board as company broadens healthcare ambition

US childhood vaccine move away from combinations contrasts with Australia’s national schedule

Patients welcome the timely PBS listing of rare cancer therapy

Follow Us

New Stories

An institution dominated by very clever people, but where is the wisdom?

A plain language version of these dreadful and useless documents

CUREator+ backs six Australian startups with $13.5 million to advance new health technologies

Medicines Australia appoints former AbbVie executive to key leadership role

VVMF and Optosleep partner to advance Australian gene therapy for sleep apnoea

Survey exposes deep gaps in neurological care across Australia

Australia 'is not an island' on pricing and we cannot be so arrogant to expect free product